ACT-based Physical Activity Program for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different physical activity programs can help adults with symptoms of depression. It compares two approaches: ACTivity, which uses Acceptance and Commitment Therapy (ACT) to encourage exercise, and Relaxercise, which focuses on relaxation training along with standard exercise advice. People who feel down and engage in less than 60 minutes of moderate exercise per week might be a good fit. Participants will attend weekly online sessions and receive a 6-month YMCA membership to support their physical activity journey. As an unphased trial, this study offers a unique opportunity to contribute to understanding how exercise can improve mental health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Acceptance and Commitment Therapy (ACT), used in the ACTivity program, is generally safe and positively impacts people with depression. Studies have found that ACT can significantly improve depression symptoms and increase physical activity. Participants reported a better quality of life and improved stress management. These studies have not reported any major safety issues.
For the Relaxercise program, which combines relaxation techniques with physical activity, specific data is less available. However, similar programs are typically safe and well-received by participants.
Both the ACTivity and Relaxercise programs in this trial aim to increase physical activity, which is generally safe and beneficial for mental health.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for depression because they incorporate unique strategies to boost physical activity, which is a key factor in mental health. The ACTivity program uses Acceptance and Commitment Therapy (ACT) to enhance motivation for physical activity, encouraging individuals to embrace their thoughts and feelings while committing to behavior changes. This approach is different from traditional depression treatments, which often focus more on medication or cognitive-behavioral therapy. Meanwhile, Relaxercise combines relaxation techniques with standard physical activity promotion, offering a holistic way to engage the body and mind. These programs aim to provide more personalized and potentially effective alternatives to traditional methods, sparking interest in their potential benefits.
What evidence suggests that this trial's treatments could be effective for depression?
This trial will compare two approaches: ACTivity and Relaxercise. Research has shown that Acceptance and Commitment Therapy (ACT), part of the ACTivity arm in this trial, can significantly improve depression symptoms and enhance mental adaptability. Past studies combining ACT with exercise have demonstrated positive effects on mental health and physical fitness, lasting up to six months post-treatment.
The Relaxercise approach, another arm in this trial, includes relaxation training and regular physical activity. Research has proven that exercise alone, such as walking, yoga, and strength training, can effectively treat depression and noticeably boost mood. Longer and more intense exercise sessions further reduce depression symptoms.
Both treatments in this trial use physical activity to ease depression, with ACTivity adding mental strategies and Relaxercise focusing on the well-known benefits of exercise.24678Who Is on the Research Team?
Da M Wil, Ph.D.
Principal Investigator
Brown University School of Public Health
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with depressive symptoms who are not very active (less than 60 minutes of moderate exercise per week). They must be able to attend weekly virtual sessions and have a stable Rhode Island address. Exclusions include extreme BMI, conditions limiting physical activity, active suicidal thoughts, participation in other related studies, non-English speakers, and regular mindfulness practitioners.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either ACT-based physical activity promotion or Relaxercise for 8 weeks
Follow-up
Participants are monitored for changes in depression symptoms and physical activity over 6 months
What Are the Treatments Tested in This Trial?
Interventions
- ACTivity
- Relaxercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brown University
Lead Sponsor
National Center for Complementary and Integrative Health (NIH)
Collaborator
National Center for Complementary and Integrative Health (NCCIH)
Collaborator